Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2002
10/16/2002CN1092654C 4-phenylpiperidine compound
10/16/2002CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/15/2002USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002US6465509 Pyrones as inhibitors of cyclooxygenase-2
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002US6465482 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/15/2002US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002US6465453 Azepine derivatives having effects on serotonin related systems
10/15/2002US6465449 Heteroaromatic bicyclic derivatives useful as anticancer agents
10/15/2002US6465259 Non radioactive receptor assay suitable for quantitative and qualitative analysis of trace amounts of receptor binding analyte
10/15/2002CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002WO2002080164A1 Optical recording medium
10/10/2002WO2002080163A1 Optical data carrier containing a cyclizable compound in the information layer
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002WO2002080150A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/10/2002WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079196A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079190A1 3-substituted indoles as chemokine antagonists
10/10/2002WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002WO2002079182A2 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines
10/10/2002WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078628A2 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
10/10/2002WO2002066440A8 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
10/10/2002WO2002062764A9 Fused heterocyclic compounds
10/10/2002WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002WO2002043667A3 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002WO2001049678A9 Substituted phenyl-piperazine derivatives, their preparation and use
10/10/2002US20020147345 FSH mimetics for the treatment of infertility
10/10/2002US20020147344 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
10/10/2002US20020147230 Cardiovascular disorders; antihistamines
10/10/2002US20020147219 Neurokinin antagonists
10/10/2002US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147181 Viricides
10/10/2002DE10117464A1 Optical data medium for information recording, has cover layer and adhesive layer having preset total thickness, and recorded and readout with focussing objective lens setup having preset numerical aperture
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002CA2442354A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
10/10/2002CA2442263A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246822A1 Benzofuran derivatives
10/09/2002EP1246821A2 Process for the preparation of paroxetine and synthetic intermeditates thereof
10/09/2002EP1246819A1 A method for the preparation of substituted benzene derivatives
10/09/2002EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use
10/09/2002EP1246815A1 Phenylpiperazinyl derivatives
10/09/2002EP1246809A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1000025A4 Substituted naphthopyrans
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1092195C N-([1,2,4]triazoloazinyl]-benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/09/2002CN1092194C Diaminopyrimidines, pharmaceutical compositions contg. them and their use as antibacterial
10/09/2002CN1092188C Substd. aminoquinazolinone (thione) derivs. or salts thereof, intermediates thereof, and pest controller and method for using same
10/09/2002CN1092022C Microbicides
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462063 N,n'-disubstituted hydantoin hydroxamates; regulating, modulating and/or inhibiting abnormal collagen formation to treat fibrotic disorders; hepatic cirrhosis, arthritis
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof